Cargando…

Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus

Diabetes mellitus is a major leading cause of end-stage renal failure, characterized by kidney inflammation and glomerular dysfunction, in worldwide. Kidney inflammation is associated to modifications in the expression levels of pro-inflammatory molecules, such as nuclear factor-κB (NFκB) and adhesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroune, Djamila, Libdiri, Farid, Leboucher, Sophie, Maouche, Boubekeur, Marco, Sergio, El-Aoufi, Salima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415148/
https://www.ncbi.nlm.nih.gov/pubmed/28490956
http://dx.doi.org/10.1016/j.sjbs.2016.05.009
_version_ 1783233476239032320
author Aroune, Djamila
Libdiri, Farid
Leboucher, Sophie
Maouche, Boubekeur
Marco, Sergio
El-Aoufi, Salima
author_facet Aroune, Djamila
Libdiri, Farid
Leboucher, Sophie
Maouche, Boubekeur
Marco, Sergio
El-Aoufi, Salima
author_sort Aroune, Djamila
collection PubMed
description Diabetes mellitus is a major leading cause of end-stage renal failure, characterized by kidney inflammation and glomerular dysfunction, in worldwide. Kidney inflammation is associated to modifications in the expression levels of pro-inflammatory molecules, such as nuclear factor-κB (NFκB) and adhesion molecules, such as E-cadherin, leading to glomerular dysfunction. However, the relationships between these two processes in human diabetic nephropathy remain an open question. Since Psammomys obesus is an ideal animal model to study diabetes mellitus temporal evolution, we have used this model to study the correlation between kidney structural changes and modification on the expression levels of NFκB and E-cadherin over time. We have demonstrated that, after induction of diabetes metillus with a high energy diet (HED), P. obesus develops the characteristic symptoms of human disease. In detail, at the third month nuclear factor NFκB is expressed in the kidney of diabetic P. obesus and structural renal changes, such as mesangial expansion or interstitial fibrosis, are detectable; at 6 months, thickening of glomerular basement membrane, glomerular sclerosis, and tubular atrophy occurs; at 9 months, symptoms of the final stages of the disease, such as down expression of E-cadherin, happens. As a result of these observations we proposed that NFκB activation and E-cadherin down-expression are interlinked on diabetic kidney disease (DKD).
format Online
Article
Text
id pubmed-5415148
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54151482017-05-10 Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus Aroune, Djamila Libdiri, Farid Leboucher, Sophie Maouche, Boubekeur Marco, Sergio El-Aoufi, Salima Saudi J Biol Sci Original Article Diabetes mellitus is a major leading cause of end-stage renal failure, characterized by kidney inflammation and glomerular dysfunction, in worldwide. Kidney inflammation is associated to modifications in the expression levels of pro-inflammatory molecules, such as nuclear factor-κB (NFκB) and adhesion molecules, such as E-cadherin, leading to glomerular dysfunction. However, the relationships between these two processes in human diabetic nephropathy remain an open question. Since Psammomys obesus is an ideal animal model to study diabetes mellitus temporal evolution, we have used this model to study the correlation between kidney structural changes and modification on the expression levels of NFκB and E-cadherin over time. We have demonstrated that, after induction of diabetes metillus with a high energy diet (HED), P. obesus develops the characteristic symptoms of human disease. In detail, at the third month nuclear factor NFκB is expressed in the kidney of diabetic P. obesus and structural renal changes, such as mesangial expansion or interstitial fibrosis, are detectable; at 6 months, thickening of glomerular basement membrane, glomerular sclerosis, and tubular atrophy occurs; at 9 months, symptoms of the final stages of the disease, such as down expression of E-cadherin, happens. As a result of these observations we proposed that NFκB activation and E-cadherin down-expression are interlinked on diabetic kidney disease (DKD). Elsevier 2017-05 2016-05-18 /pmc/articles/PMC5415148/ /pubmed/28490956 http://dx.doi.org/10.1016/j.sjbs.2016.05.009 Text en © 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Aroune, Djamila
Libdiri, Farid
Leboucher, Sophie
Maouche, Boubekeur
Marco, Sergio
El-Aoufi, Salima
Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus
title Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus
title_full Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus
title_fullStr Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus
title_full_unstemmed Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus
title_short Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus
title_sort changes in the nfκb and e-cadherin expression are associated to diabetic nephropathy inpsammomys obesus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415148/
https://www.ncbi.nlm.nih.gov/pubmed/28490956
http://dx.doi.org/10.1016/j.sjbs.2016.05.009
work_keys_str_mv AT arounedjamila changesinthenfkbandecadherinexpressionareassociatedtodiabeticnephropathyinpsammomysobesus
AT libdirifarid changesinthenfkbandecadherinexpressionareassociatedtodiabeticnephropathyinpsammomysobesus
AT lebouchersophie changesinthenfkbandecadherinexpressionareassociatedtodiabeticnephropathyinpsammomysobesus
AT maoucheboubekeur changesinthenfkbandecadherinexpressionareassociatedtodiabeticnephropathyinpsammomysobesus
AT marcosergio changesinthenfkbandecadherinexpressionareassociatedtodiabeticnephropathyinpsammomysobesus
AT elaoufisalima changesinthenfkbandecadherinexpressionareassociatedtodiabeticnephropathyinpsammomysobesus